Previously, we developed a diagnostic marker for MS based on the ability of serum autoantibodies from experimental autoimmune encephalomyelitis (EAE) mice28 and MS patients29 to recognize and hydrolyse specific epitopes within myelin basic protein (MBP). Here, MBP is linked to myeloid sarcoma.